Full-Time

Senior Marketing & Transformation Business Partner

Varian

Varian

5,001-10,000 employees

Tech-enabled radiation oncology hardware and software

Compensation Overview

$107.1k - $147.2k/yr

+ Commission

Company Historically Provides H1B Sponsorship

Remote in USA

Remote

Must work Eastern Time Zone business hours with overlap with European and Pacific Time Zone hours; travel up to 10%.

Bachelor's

Category
Business & Strategy (1)
Required Skills
Agile
CRM
Marketing

Get referred to Varian

See people who can refer or advise you

Requirements
  • A university degree in Business Administration, Marketing, Communications, Digital Business, or a related field.
  • At least 8 years of professional experience in Marketing, Commercial/Sales Excellence, Business Transformation, Campaign Management, or Marketing Consulting.
  • A proven track record of leading or supporting business transformation, marketing and sales team enablement, or digital marketing transformation initiatives within a complex B2B environment.
  • Experience working with multiple senior stakeholders across global matrix organizations.
  • Excellent stakeholder management, cross-functional project management, consulting, facilitation, and change leadership skills.
  • Strong understanding of full-funnel processes, sales enablement, customer engagement, and campaign execution models.
  • Outstanding communication, presentation, and facilitation skills in English.
  • Strong business acumen, strategic thinking, and understanding of stakeholder objectives and organizational dynamics.
  • Strong ability to influence and align senior stakeholders without formal authority, including networking and building trusted relationships.
  • Strong moderation, workshop facilitation, and stakeholder engagement skills.
  • Familiarity with Agile, Design Thinking, Structured Problem Solving, and other transformation methodologies.
  • Ability to translate business requirements into actionable initiatives and manage multiple complex initiatives simultaneously.
  • Willingness to travel nationally and internationally up to 10%.
  • Ability to work regularly within Eastern Time Zone business hours and maintain overlap with European and Pacific Time Zone working hours.
Responsibilities
  • Act as the primary senior transformation partner and interface for selected global Business Lines.
  • Build relationships with Business Line leaders to understand business priorities, capability needs, and market challenges and opportunities.
  • Represent Business Line priorities and requirements in global planning, governance, and transformation discussions.
  • Coordinate and drive change and transformation initiatives for new processes, platforms, tools, artificial intelligence use cases, playbooks, and scalable ways of working across the Business Lines.
  • Share best practices and support onboarding of Business Line stakeholders.
  • Foster consistent go-to-market execution across digital, offline, and sales touchpoints.
  • Improve sales-marketing collaboration and handover quality.
  • Drive better use of go-to-market platforms, tools, and data.
  • Act as a trusted advisor to Business Line stakeholders.
  • Ensure efficient planning, coordination, and execution of marketing initiatives and stakeholder alignment processes.
  • Advise on how to best leverage central marketing and sales capabilities, platforms, and services.
  • Drive adoption of marketing campaigns and sales enablement practices that improve commercial effectiveness, strengthen customer engagement, and support business growth.
  • Collect, consolidate, and prioritize business requirements, capability demands, and Business Line feedback to inform global transformation strategies and advise central functions on adoption plans.
  • Partner with Business Line leaders to identify capability gaps and define scalable enablement, process, and transformation measures.
  • Collaborate with marketing, sales, operations, and platform teams to ensure successful execution of strategic initiatives and monitor adoption, readiness, business impact, and benefit realization across the Business Lines.
  • Advocate for audience-centric, local-first, and data-driven decision making across marketing and commercial teams.
Desired Qualifications
  • Strong understanding of B2B go-to-market models, preferably in MedTech, healthcare technology, life sciences, or another complex enterprise environment.
  • Experience with customer relationship management, marketing automation, sales enablement platforms, or commercial data-driven operating models.

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for photon FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, expanding addressable uses beyond cancer.
  • CE mark for Eclipse AI contouring in May 2026 accelerates European software uptake.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium, pressuring Varian's software moat by 2026.
  • PwC's April 2026 Tax Court loss narrows Varian's Section 245A benefit and cash flexibility.
  • If Ethos and Eclipse lose workflow leadership, Varian becomes a commodity linac vendor.

What makes Varian unique

  • TrueBeam, Ethos, Halcyon, and Eclipse create a tightly integrated imaging-to-treatment stack.
  • Siemens Healthineers gives Varian direct hospital access and shared imaging distribution worldwide.
  • Varian controls over 60 percent market share after adding AI planning and adaptive radiotherapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Health Insurance

Dental Insurance

Vision Insurance

Wellness Program

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

5%
MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.

PR Newswire
Jul 29th, 2024
Varian Announces Future-Focused, Integrated Microwave Ablation Ecosystem With Intelliblate

PALO ALTO, Calif., July 29, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, announces receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IntelliBlate microwave ablation system, intended for ablation of soft tissue. Designed to provide clinicians with greater predictability, precision, and control during their procedures, IntelliBlate serves as the cornerstone of a future-focused, integrated ecosystem for microwave ablation.IntelliBlate produces large, controlled spherical ablation zones for predictable treatment delivery. With the option to utilize a single or dual probes – each with linked or independent controls – IntelliBlate delivers the versatility to meet the unique clinical needs of each patient. Precision and control are amplified by the Ximitry probe, which enables innovative features such as Laser Disk Alignment and intuitive LED indicators.The compact, versatile design and intuitive interface of IntelliBlate delivers a portable and flexible system that reduces barriers for this important treatment method. Modular elements provide the flexibility for clinicians to expand their treatment capabilities to meet changing clinical demands, all while keeping control over operational efficiency throughout the ablation procedure."IntelliBlate combines the features our customers say are most important for an efficient, integrated solution to seek improved levels of performance in microwave ablation," says Dr